2 studies found for:    NCT01183468
Show Display Options
Rank Status Study
1 Suspended A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part I
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Alpha 1-Antitrypsin;   Biological: Alpha-1 Antitrypsin
2 Withdrawn A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Aralast NP;   Drug: Placebo

Indicates status has not been verified in more than two years